Over the past year, leadership in the development of frontier open-source AI models has shifted from the United States to China, beginning with the release of DeepSeek in late 2024.

Over the past year, AI drug discovery models have advanced from designing simple molecules to designing full-length antibodies with drug-like properties using zero-shot methods.

A speaker predicts that 2026 will be the "year of deployment" for AI drug discovery, where the technology moves from a research phase to practical application.

A speaker predicts that in the next year, the United States will regain its leadership position in developing the largest and most capable open-weight AI models.

A speaker predicts that in the next year, it will become clear that viable alternatives to NVIDIA's GPUs exist for AI workloads outside of Google's ecosystem.